Global Oncology Drug Market is expected to reach XX Billion by 2026 from 95.38 Billion in 2018 at CAGR of XX % (Detailed analysis of the market CAGR is provided in the report). Global Oncology Drug Market is segmented on the basis of Therapeutic Modalities, Cancer types, and Geography. The increasing demand of biological and targeted drug therapies, the rising prevalence of various types of cancer, rising impact of biosimilars, and continuous patent expiry of key cancer drugs are the major factors driving the growth of Global Oncology Drug Market. However, the adverse effects of cancer drug therapy and a threat of failure, and the high cost of drug development are the key restraining factors for market growth. Owing to the high efficacy of the drug based on monoclonal antibodies have gained attention in recent years, which is expected to further furl the growth of the market. Initiatives were taken by USFDA and European Union to fuel the growth of the global oncology drug market by offering pre-market approval for potential drugs under clinical development. North America is anticipated to dominate the overall oncology drug market, owing to the large presence of companies engaged in the development of cancer drugs. Europe is the second largest revenue generating region for global oncology drug market. The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Oncology Drug Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence. To understand the market dynamics and by region, the report has covered the PEST analysis by region and key economies across the globe, which are supposed to have an impact on market in forecast period. PORTER’s analysis, and SVOR analysis of the market as well as detailed SWOT analysis of key players has been done to analyze their strategies. The report will to address all questions of shareholders to prioritize the efforts and investment in the near future to the emerging segment in the Global Oncology Drug Market. Key Highlights: • Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for Global Oncology Drug Market during the forecast period • Complete quantitative analysis of the industry from 2017 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Oncology Drug Market analysis and comprehensive segmentation with respect to the Therapeutic modalities, Cancer Types, and geography to assist in strategic business planning. • Global Oncology Drug market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their key regions Years that have been considered for the study are as follows: • Base Year - 2018 • Estimated Year - 2019 • Forecast Period - 2019 to 2026 For company profiles, 2018 has been considered as the base year. In cases, wherein information was unavailable for the base year, the years prior to it have been considered Research Methodology: The research methodology used in Global Oncology Drug Market report contains various secondary sources including directories such as a study of company websites, stock analysis presentation, national and international database, annual reports and press releases. Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Automotive Temperature Sensor market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of Global Oncology Drug Market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Oncology drug market globally. Key Players in the Oncology Drug Market Are: • Pfizer • Merck and company • Novartis • Glaxo Smith Kline PLC • Johnson and Johnson • Amgen • Roche Diagnostics • Eli Lilly and company • Celgene Corporation • Sanofi Key Target Audience: • Pharmaceutical and Biotechnological Companies • Venture Capitalists and Investors • Medical Research Laboratories • Hospitals and clinics • Research and Development Organizations • Business Research and Consulting Service providers • Drug Manufacturers and suppliers • Academic Research Institutes • Academic Medical Centers and universities • Government and regulatory authorities The scope of the Report: Research report categorizes the Global Oncology Drug Market based on Therapeutic Modalities, Cancer Types, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Oncology Drug market with key developments in companies and market trends. Oncology Drug Market, By Therapeutic Modalities: • Chemotherapy • Targeted Therapy • Immunotherapy • Hormonal Oncology Drug Market, By Cancer Type: • Blood Cancer • Breast Cancer • Gastrointestinal Cancer • Prostate • Skin Cancer • Respiratory Oncology drug Market, By Geography: • North America • Europe • Asia Pacific • Middle East & Africa • Latin America Available Customization: Maximize Market Research offers customization of report and scope of the report as per the specific requirement of our client.
Table of Contents
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. ONCOLOGY DRUG MARKET, BY THERAPEUTIC MODALITIES (2019-2026) 5.1. Introduction 5.2. Chemotherapy 5.2.1. Chemotherapy Market Overview 5.2.2. Chemotherapy Market Size & Forecast 5.3. Targeted Therapy 5.3.1. Targeted Therapy Market Overview 5.3.2. Targeted Therapy Market Size & Forecast 5.4. Immunotherapy 5.4.1. Immunotherapy Market Overview 5.4.2. Immunotherapy Market Size & Forecast 5.5. Hormonal 5.5.1. Hormonal Market Overview 5.5.2. Hormonal Market Size & Forecast 6. GLOBAL ONCOLOGY DRUG MARKET, BY CANCER TYPE (2019-2026) 6.1. Introduction 6.2. Blood Cancer 6.2.1. Blood Cancer Market Overview 6.2.2. Blood Cancer Market Size & Forecast 6.3. Breast Cancer 6.3.1. Breast Cancer Market Overview 6.3.2. Breast Cancer Market Size & Forecast 6.4. Gastrointestinal Cancer 6.4.1. Gastrointestinal cancer Market Overview 6.4.2. Gastrointestinal Market Size & Forecast 6.5. Prostate cancer 6.5.1. Prostate Cancer Market Overview 6.5.2. Prostate Cancer Market Size & Forecast 6.6. Skin Cancer 6.6.1. Skin Cancer Market Overview 6.6.2. Skin cancer Market Size & Forecast 6.7. Respiratory Cancer 6.7.1. Respiratory Cancer Market Overview 6.7.2. Respiratory Cancer Market Size & Forecast 7. GLOBAL ONCOLOGY DRUG MARKET, BY GEOGRAPHY (2019-2026) 7.1. North America Global Oncology Drug Market 7.1.1. North America Global Oncology Drug Market, by Therapeutic Modalities 7.1.2. North America Oncology Drug Market, by Cancer Type 7.1.3. North America Global Oncology Drug Market, by Region 188.8.131.52. U.S. Global Oncology Drug Market 184.108.40.206. Canada Oncology Drug Market 220.127.116.11. Mexico Oncology Drug Market 7.2. Europe Global Oncology Drug Market 7.2.1. Europe Oncology Drug Market, by Therapeutic Modalities 7.2.2. Europe Oncology Drug Market, by cancer Type 7.2.3. Europe Oncology Drug Market, by Region 18.104.22.168. France Oncology Drug Market 22.214.171.124.